Back to Search
Start Over
PDB36 LONG-TERM Cost-Effectiveness Analyses of Once-Weekly Semaglutide 1 MG Versus Empagliflozin 25 MG for Treatment of Type 2 Diabetes in Three Countries: Bosnia and Herzegovina, Greece, and Slovenia
- Source :
- Value in Health. 23:S512
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
Details
- ISSN :
- 10983015
- Volume :
- 23
- Database :
- OpenAIRE
- Journal :
- Value in Health
- Accession number :
- edsair.doi...........357dbbaa7885f6bb8ce840a3df1263bf